英国炎症性肠病流行病学与结局变化:2000-2018年
基于英国国家初级保健数据库2000-2018年数据,研究炎症性肠病(IBD)的发病率、患病率及结直肠癌和全因死亡风险。溃疡性结肠炎(UC)和克罗恩病(CD)患病率均上升,预计2025年IBD患病率达1.1%;UC患者结直肠癌风险增加(aHR 1.40),UC和CD全因死亡风险均增加。
要点
- UC患病率从390/10万升至570/10万,CD从220/10万升至400/10万(2000-2017)。
- UC患者结直肠癌风险较对照增加(aHR 1.40,95%CI 1.23-1.59)。
- UC和CD全因死亡风险增加,aHR分别为1.17和1.42。
核心结论
- 英国IBD患病率高于既往报道,预计2025年患病率达1.1%。
- UC患者结直肠癌风险增加,UC和CD全因死亡风险均增加。
研究设计与样本
- 基于英国国家初级保健数据库2000-2018年IBD病例的回顾性队列研究。
- 采用年龄/性别匹配的回顾性队列研究分析IBD与结直肠癌及全因死亡的关联。
- 患病率预测至2025年。
主要发现
- UC患病率从2000年390/10万增至2017年570/10万;CD从220/10万增至400/10万。
- 2017年男性CD患病率0.35%(95%CI 0.34-0.36),女性0.44%(0.43-0.45)。
- UC和CD发病率分别为23.2(22.8-23.6)/10万人年和14.3(14.0-14.7)/10万人年。
- UC患者结直肠癌风险增加(aHR 1.40 [1.23-1.59]),结直肠癌发生率随时间保持稳定。
- UC和CD全因死亡风险增加,aHR分别为1.17(1.14-1.21)和1.42(1.36-1.48)。
临床怎么用
- 英国IBD患病率持续上升,需关注医疗资源规划。
- UC患者应重视结直肠癌监测。
- IBD患者需关注全因死亡风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data regarding incidence, prevalence and long-term outcomes of inflammatory bowel diseases in the UK are limited or outdated. AIMS: To investigate incidence and prevalence of Crohn's disease and ulcerative colitis and risk of colorectal cancer and all-cause mortality in these diseases. METHODS: Inflammatory bowel disease cases between 2000 and 2018 were identified from a national primary care database. Inflammatory bowel disease prevalence was forecast until 2025. The association between inflammatory bowel disease and colorectal cancer and all-cause mortality was investigated using age/sex-matched retrospective cohort studies. Hazard ratios were adjusted for age, sex, deprivation, comorbidity, smoking status and body mass index. RESULTS: Ulcerative colitis prevalence increased from 390 to 570 per 100 000 population from 2000 to 2017. Prevalence of Crohn's disease increased from 220 to 400 per 100 000. In 2017 male Crohn's disease prevalence was 0.35% (95% confidence interval 0.34-0.36); female prevalence was 0.44% (0.43-0.45). Prevalence of inflammatory bowel disease is predicted to be 1.1% by 2025. Incidence of ulcerative colitis and Crohn's disease was 23.2 (22.8-23.6) and 14.3 (14.0-14.7) per 100 000 person-years respectively. Subjects with ulcerative colitis were more likely to develop colorectal cancer than controls (adjusted Hazard Ratio 1.40 [1.23-1.59]). Colorectal cancer rates remained stable in inflammatory bowel diseases over time. Ulcerative colitis and Crohn's disease were associated with increased risk of all-cause mortality (1.17 [1.14-1.21] and 1.42 [1.36-1.48] respectively). CONCLUSIONS: The UK prevalence of inflammatory bowel disease is greater than previous reports suggest and we predict an 11% increase in prevalence by the year 2025. Mortality risk in inflammatory bowel disease and colorectal cancer risk in ulcerative colitis are increased compared to matched controls.
引用
- King D, Reulen RC, Thomas T, et al. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018. Aliment Pharmacol Ther. 2020. PMID: 32237083. doi:10.1111/apt.15701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。